Valuation Roche Holding AG

Equities

Market Closed - Swiss Exchange Other stock markets 16:31:28 07/11/2025 GMT			5-day change	1st Jan Change
268.40 ^CHF	+1.21%		+3.67%	+5.05%

11-07	Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer 40th Annual Meeting	CI
11-07	America's markets lose their nerve

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	264,244	306,810	239,812	197,073	205,191	229,961	-	-
Change	-	16.11%	-21.84%	-17.82%	4.12%	12.07%	-	-
Enterprise Value (EV) ¹	266,126	324,977	255,396	215,772	222,528	243,242	238,110	230,246
Change	-	22.11%	-21.41%	-15.51%	3.13%	9.31%	-2.11%	-3.3%
P/E ratio	18.7x	23.4x	18.9x	17.1x	24.8x	16x	14.4x	13.6x
PBR	7.27x	13.2x	8.29x	5.91x	5.67x	5.56x	4.66x	4x
PEG	-	-12.08x	-3.69x	-2.48x	-0.9x	0.3x	1.3x	2.15x
Capitalization / Revenue	4.53x	4.89x	3.79x	3.36x	3.39x	3.73x	3.64x	3.54x
EV / Revenue	4.56x	5.17x	4.04x	3.67x	3.68x	3.95x	3.77x	3.54x
EV / EBITDA	11x	13.2x	10.2x	9.82x	9.45x	9.91x	9.3x	8.68x
EV / EBIT	12.4x	14.8x	11.5x	11.2x	10.7x	11.2x	10.6x	9.81x
EV / FCF	24.3x	20.7x	19.6x	19.1x	14.5x	16.2x	14.6x	13.6x
FCF Yield	4.11%	4.83%	5.11%	5.23%	6.89%	6.19%	6.87%	7.36%
Dividend per Share ²	9.1	9.3	9.5	9.6	9.7	9.893	10.1	10.31
Rate of return	2.94%	2.45%	3.27%	3.93%	3.8%	3.69%	3.76%	3.84%
EPS ²	16.52	16.2	15.37	14.31	10.31	16.8	18.62	19.8
Distribution rate	55.1%	57.4%	61.8%	67.1%	94.1%	58.9%	54.2%	52.1%
Net sales ¹	58,323	62,801	63,281	58,716	60,495	61,577	63,121	64,986
EBITDA ¹	24,281	24,692	25,015	21,976	23,538	24,544	25,595	26,515
EBIT ¹	21,536	21,897	22,173	19,240	20,823	21,633	22,502	23,466
Net income ¹	14,295	13,930	12,421	11,498	8,277	13,038	14,547	15,448
Net Debt ¹	1,882	18,167	15,584	18,699	17,337	13,282	8,149	285.6
Reference price ²	309.00	379.10	290.50	244.50	255.50	268.40	268.40	268.40
Nbr of stocks (in thousands)	854,642	800,952	800,579	798,652	796,789	850,317	-	-
Announcement Date	04/02/21	03/02/22	02/02/23	01/02/24	30/01/25	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ROCHE HOLDING AG	15.78x	3.91x	9.81x	3.73%	282B
ELI LILLY AND COMPANY	41.51x	13.68x	30.6x	0.64%	839B
JOHNSON & JOHNSON	16.91x	5.02x	13.9x	2.76%	450B
ABBVIE INC.	46.86x	7.28x	17.18x	2.98%	387B
ASTRAZENECA PLC	25.29x	4.78x	14x	1.91%	261B
NOVARTIS AG	17.47x	4.75x	11.3x	3.2%	242B
MERCK & CO., INC.	10.85x	3.71x	7.98x	3.77%	213B
NOVO NORDISK A/S	13.16x	4.77x	9.77x	3.78%	211B
AMGEN INC.	25.55x	5.94x	10.19x	3.01%	170B
GILEAD SCIENCES, INC.	17.95x	5.69x	10.4x	2.68%	153B
Average	23.13x	5.95x	13.51x	2.85%	320.87B
Weighted average by Cap.	27.44x	7.40x	17.09x	2.42%